Understanding the impact of Type 1 Diabetes on caregivers in Canada
Burden and (Dis)Utility of Caregivers of Children With T1D
This study looks at how caring for a child with Type 1 Diabetes affects the lives of their caregivers in Canada to better understand their challenges and needs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | PeriPharm Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT06786130 on ClinicalTrials.gov |
What this trial studies
This observational study aims to estimate the societal burden associated with Type 1 Diabetes (T1D) on caregivers of children diagnosed with the condition within the last two years. It will assess factors such as work productivity, healthcare resource utilization, and the overall quality of life of these caregivers. Participants will complete a 20-minute survey to provide insights into their experiences and challenges. The study focuses on real-world implications and aims to gather valuable data to inform future support and resources for caregivers.
Who should consider this trial
Good fit: Ideal candidates for this study are parental caregivers of children recently diagnosed with Type 1 Diabetes who are willing to participate in a survey.
Not a fit: Patients who are not caregivers or those who have not been recently diagnosed with T1D will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved support systems and resources for caregivers of children with Type 1 Diabetes.
How similar studies have performed: While this study focuses on a specific caregiver perspective, similar observational studies have shown success in understanding the burdens of chronic conditions on families.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Parental caregiver of a child recently diagnosed (\<= 2 years) with T1D before study inclusion; 2. Age ≥18 ; 3. Residence in the Canada; 4. Willingess to complete a 20-minute survey 5. Ability to read and understand French or English; 6. Signature of informed consent form (ICF) Exclusion Criteria: 1\. Participation in a clinical trial.
Where this trial is running
Montreal, Quebec
- PROxy Network, an initiative of PeriPharm Inc. — Montreal, Quebec, Canada (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.